Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 14, 2015; 21(42): 12114-12124
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12114
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12114
Table 1 Classification and characteristics of the main matrix metalloproteinases
| MMP (class and number) | Name | Extracellular Matrix substrate |
| Collagenases | ||
| MMP-1 | Collagenase 1 | Collagen I, II, III, VII, VIII and X, gelatin, proteoglycans, tenascin, entactin |
| MMP-8 | Collagenase 2 | Collagen I, II, III, V, VIII and X, gelatin, aggrecan |
| MMP-13 | Collagenase 3 | Collagen I, II, III, IV, IX and X, fibronectin, gelatin, tenascin, aggrecan, osteonectin |
| Gelatinases | ||
| MMP-2 | Gelatinase A | Collagen I, IV, V, VII, IX and X, gelatin, proteoglycans, elastin, fibronectin, laminin, aggrecan, versican, osteonectin |
| MMP-9 | Gelatinase B | Collagen IV, V, VII, X and XIV, gelatin, proteoglycans, elastin, aggrecan, versican, osteonectin |
| Stromelysins | ||
| MMP-3 | Stromelysins 1 | Collagen III, IV, V, and IX, gelatin, proteoglycans, tenascin, fibronectin, laminin, aggrecan, versican, osteonectin |
| MMP-10 | Stromelysins 2 | Collagen III, IV and V, gelatin, proteoglycans, aggrecan, elastin, casein |
| MMP-11 | Stromelysins 3 | Collagen IV, fibronectin, laminin, gelatin, transferrin |
| Membrane type | ||
| MMP-14 | MT1-MMP | Collagen I, II and III, fibronectin, vitronectin, tenascin, laminin, proteoglycans, aggrecan, elastin, casein, entactin |
| MMP-15 | MT2-MMP | Fibronectin, tenascin, laminin |
| MMP-16 | MT3-MMP | Collagen III, fibronectin, casein, gelatin |
| MMP-17 | MT4-MMP | ND |
| MMP-24 | MT5-MMP | Activator of proMMP-2 |
| MMP-25 | MT6-MMP | Collagen IV, fibronectin, gelatin, fibrinogen |
| Others | ||
| MMP-7 | Collagen IV and X, gelatin, proteoglycans, tenascin, fibronectin, laminin, aggrecan, osteonectin, entactin, casein, tranferrin, integrin b4 | |
| MMP-12 | Collagen IV, gelatin, proteoglycans, fibronectin, laminin, entactin, casein, vibronectin, elastin | |
| MMP-19 | ND | Aggrecan, cartilage oligomeric matrix protein (COMP) |
| MMP-20 | Enamelysin | Amelogenin |
| MMP-23A | MMP-21 | ND |
| MMP-23B | MMP-22 | ND |
| MMP-26 | Matrilysin 2 | Collagen IV, fibronectin, casein, fibrinogen |
| MMP-27 | ND | ND |
| MMP-28 | Epilysin | Casein |
Table 2 Synthetic compounds involved in matrix metalloproteinase regulation
| Compounds | Mechanism involved | MMPs involved | I/R model | Ref. |
| Bortezomib | Downregulation of pro-inflammatory (IL-1β, TNF-α and IFN-γ) and pro-fibrotic (VEGF, TGF-β, HGF, bFGF) factors | MMP-2MMP-9 | Steatotic orthotopic liver transplant | Tiriveedhi et al[45],Transpl Immunol 2014 |
| KMUP-1 (NO-donor) | Protects from apoptosis-associated free radical generation and pro-inflammation | MMP-9 | Hypoxic HepG2 cells | Kuo et al[90], Int J Imm Pharm 2013 |
| CS-1 peptide | Blocks fibronectin α4β1 and decreases the release of pro-inflammatory mediators | MMP-9MT-1-MMP/MMP-14 | Cold ischemia | Duarte et al[91],Am J Transpl 2012 |
| CTT peptide | Reduction in TNF-α, IL-1, IL-2 and IFN-γ | MMP-9 | Acute small-for-size liver graft | Ma et al[34], Am J Transpl 2010 |
| Cyclic RGD peptide | Depresses inflammatory mediators (IFN-γ) | MMP-9 | Steatotic Cold ischemia | Fondevila et al[92],Am J Transpl 2009 |
| ONO-1714 | iNOS inhibitor | MMP-9 | Warm ischemia | Hamada et al[46], Am J Pathol 2009 |
| RXP409 | Inhibitory effects on MMP activity | MMPs | Cold ischemia | Defamie et al[28],Hepatology 2008 |
| Anti-MMP-9 | Decrease in expression of TNF-α, IL-2 and IFN-γ | MMP-9 | Warm ischemia | Hamada et al[23], Hepatology 2008 |
| CS-1 peptide | Blocks FN α4β1 integrin and its FN ligand | MMP-9 | Steatotic orthotopic liver transplant | Moore et al[29], Am J Pathol 2007 |
| ONO-4817 | Reduction in TNF-α, IL-1β | MMP-2 and MMP-9 | Warm ischemia | Shirahane et al[33],Surgery 2006 |
| NAC | Reduction in free radicals | MMP-9 | Warm ischemia | Chen et al[93], Transpl Proc 2005 |
| BB3103 | Prostaglandin PGE(1) protection | MMP-2 | Cold ischemia | Yang et al[94], Microvasc Res 2002 |
| RXPO3 | Protects from necrosis/apoptosis | MMP-3-9-11-13 | Warm ischemia | Cursio et al[24], FASEB J 2002 |
Table 3 Endogenous factors associated with matrix metalloproteinase modulation
| Factors | MMPs Involved | I/R Model | Ref. |
| FN-α-β1 | MMP-9MT1-MMP/MMP-14 | Cold ischemia | Duarte et al[91], Am J Transpl 2012 |
| Coito[48], Curr Opin Organ Transplant 2011 | |||
| Moore et al[29], Am J Pathol 2007 | |||
| Fondevilla et al[95], Transplant Proc 2005 | |||
| Amersi et al[47], Am J Pathol 2003 | |||
| Tenascin-C | MMP-9 | Warm ischemia | Kuriyama et al[96], Hepatology 2011 |
| iNOS | MMP-9 | Warm ischemia | Hamada et al[46], Am J Pathol 2009 |
| TNF-α | MMP-2 and MMP-9 | Warm ischemia | Feng et al[39], J Surg Res 2013 |
| Palladini et al[43], Toxicol and Pathol 2012 | |||
| Khandoga et al[26], J Leukoc Biol 2006 | |||
| Chen et al[93], Transplant Proc 2005 | |||
| IL-1β | MMP-2 and MMP-9 | Warm ischemia | Shirahane et al[33], Surgery 2006 |
| IL-6 | MMP-9 | Warm ischemia | Hamada et al[46], Am J Pathol 2009 |
| IFNα-2a | MMP-2 and MMP-9 | Cholestasis | Bueno et al[54], J Hepatol 2000 |
| CD62 | MMP-2 and MMP-9 | Warm ischemia | Khandoga et al[26], J Leukoc Biol 2006 |
| Plasmin | MMP-9 | Cholestasis | Martínez-Rizo et al[97], Liver Int 2010 |
| TGF-β | MMP-9 | Warm ischemia | Feng et al[39], J Surg Res 2013 |
| MMP-13 | Cholestasis | Aldaba-Muruato et al[98], Can J Physiol Pharmacol 2012 | |
| IL-10 | MMP-2 and MMP-9 | Warm ischemia | Feng et al[99], Int Immunopharmacol 2012 |
- Citation: Palladini G, Ferrigno A, Richelmi P, Perlini S, Vairetti M. Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review. World J Gastroenterol 2015; 21(42): 12114-12124
- URL: https://www.wjgnet.com/1007-9327/full/v21/i42/12114.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i42.12114
